Pages that link to "Q52949435"

The following pages link to A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations. (Q52949435):

Displaying 14 items.

• Applying complexed prostate-specific antigen to clinical practice (Q35769166) (← links)
• The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers (Q35861497) (← links)
• Blood biomarkers for prostate cancer detection and prognosis (Q36895818) (← links)
• New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer (Q36973830) (← links)
• New circulating biomarkers for prostate cancer (Q36999680) (← links)
• Emerging biomarkers of prostate cancer (Review) (Q38013967) (← links)
• Advances in Prostate-Specific Antigen Testing (Q39418149) (← links)
• Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL. (Q39739293) (← links)
• Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage? (Q42243425) (← links)
• PSA and hK2 in the diagnosis of prostate cancer (Q46462616) (← links)
• Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA. (Q47291842) (← links)
• Les formes moléculaires du PSA (Q63966245) (← links)
• [The role of PSA in diagnosis of prostate cancer and its recurrence] (Q81332660) (← links)
• [Value of biomarkers in urology] (Q84021943) (← links)